The Effects of Ketogenic Diets on Inflammation and Chronic Pain

生酮饮食对炎症和慢性疼痛的影响

• 批准号: 7981181
• 负责人: David Nathaniel Ruskin
• 金额: $ 22.36万
• 依托单位: TRINITY COLLEGE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7981181
• 关键词: Absence of pain sensation; Acute; Address; Adenosine; Adverse effects; Analgesics; Animal Model; Anti-Inflammatory Agents; Anti-inflammatory; Anticonvulsants; Arthritis; Atkins Diet; Basic Science; Biochemical; Blood; Caloric Restriction; Carbohydrates; Childhood; Chronic; Chronic Brain Injury; Clinical; Development; Diabetes Mellitus; Diet; Disease; Epilepsy; Extravasation; Fatty acid glycerol esters; Freund' s Adjuvant; Goals; Healthcare Industry; Heating; Human; Hydroxybutyrates; Hyperalgesia; Inflammation; Inflammatory; Injection of therapeutic agent; Intractable Epilepsy; Intractable Pain; Ketones; Ketoses; Ketosis; Lead; Measures; Metabolism; Nature; Neuromodulator; Neurons; Neuropathy; Nociception; Opiates; Opioid; Pain; Pain Threshold; Pain management; Peroxisome Proliferator-Activated Receptors; Pharmaceutical Preparations; Physiological; Plasma; Proteins; Reactive Oxygen Species; Refractory; Regimen; Rheumatoid Arthritis; Swelling; Tactile; Tactile Hyperalgesias; Testing; Therapeutic; Tissues; Work; allodynia; base; behavior measurement; chronic pain; clinical efficacy; cost; effective therapy; glucose metabolism; inflammatory neuropathic pain; inflammatory pain; ketogenesis; ketogenic diet; ketogentic; nerve injury; neuroprotection; novel; novel therapeutics; painful neuropathy; palliative; prevent; public health relevance; relating to nervous system; research study; sciatic nerve; subcutaneous; success; tool

DESCRIPTION (provided by applicant): A great unmet need exists for pain therapies that are non-addictive and/or address pain that remains intractable to treatments available currently. Opiates, the most powerful drugs to treat pain, pose serious side effects and addictive potential and are sometimes ineffective. Two major non-opioid strategies to address pain are focused on either reducing inflammation and inflammatory pain (particularly relevant to arthritis) or reducing neural activity and neuropathic pain (particularly relevant to diabetes and nerve injury). There is emerging evidence to suggest that a ketogenic diet may alleviate pain. A ketogenic diet is a regimen that it is high in fat and low in carbohydrates, similar to the Atkins diet. The carbohydrate restriction decreases the metabolism of glucose and increases the metabolism of ketones. To date, the ketogenic diet has shown proven clinical efficacy in epilepsy and demonstrated basic research potential for neuroprotection in several types of acute and chronic brain injuries. A number of biochemical consequences of a ketogenic diet - decreased reactive oxygen species, decreased neural activity, increased adenosine and activation of peroxisome proliferator-activated receptors - all suggest that a ketogenic diet will be effective in increasing baseline pain thresholds and reducing both inflammatory and neuropathic pain. Our central hypothesis is that a ketogenic diet will alleviate pain, including intractable pain, based on its anti-inflammatory potential and akin to its success in treating intractable epilepsy. Despite multiple lines of evidence supporting our central hypothesis, the efficacy of a ketogenic diet in treating pain has not been tested either clinically or in animal models. The present objective is to test the effects of a ketogenic diet on baseline pain thresholds, inflammatory pain (Specific Aim 1) and neuropathic pain (Specific Aim 2). Testing our hypothesis in well-established animal models is feasible and may yield new therapeutic opportunities for pain relief and a new avenue for developing pain treatments that are both effective and non-addictive. PUBLIC HEALTH RELEVANCE: Chronic pain is a common and debilitating condition, strikingly reducing the costing the health care industry tens of billions of dollars annually. Evidence suggests that a ketogenic (very low carbohydrate/high fat) diet should provide relief in two types of chronic pain, inflammatory and neuropathic pain, found most commonly in rheumatoid arthritis and diabetes, respectively. This proposal will quantify the preventative and palliative effects of two ketogenic diets in well-characterized animal models of inflammatory and neuropathic pain.

描述（由申请人提供）：对于非成瘾性和/或解决目前可用治疗仍然难以治疗的疼痛的疼痛疗法存在巨大的未满足需求。阿片类药物是治疗疼痛的最有效药物，具有严重的副作用和成瘾潜力，有时无效。解决疼痛的两种主要非阿片类药物策略集中在减少炎症和炎性疼痛（特别是与关节炎相关）或减少神经活动和神经性疼痛（特别是与糖尿病和神经损伤相关）。 有新的证据表明，生酮饮食可以减轻疼痛。生酮饮食是一种高脂肪低碳水化合物的饮食方案，类似于阿特金斯饮食。碳水化合物限制降低了葡萄糖的代谢，增加了酮的代谢。到目前为止，生酮饮食已在癫痫中显示出经证实的临床疗效，并在几种类型的急性和慢性脑损伤中显示出神经保护的基础研究潜力。生酮饮食的许多生化后果-活性氧减少，神经活动减少，腺苷增加和过氧化物酶体增殖物激活受体的激活-都表明生酮饮食将有效提高基线疼痛阈值并减少炎症和神经性疼痛。 我们的中心假设是，生酮饮食将缓解疼痛，包括顽固性疼痛，基于其抗炎潜力，类似于其在治疗顽固性癫痫方面的成功。尽管有多条证据支持我们的中心假设，但生酮饮食治疗疼痛的功效尚未在临床或动物模型中进行测试。本研究的目的是测试生酮饮食对基线疼痛阈值、炎性疼痛（具体目标1）和神经性疼痛（具体目标2）的影响。在完善的动物模型中测试我们的假设是可行的，可能会产生新的缓解疼痛的治疗机会，并为开发有效且不成瘾的疼痛治疗提供新的途径。 公共卫生关系：慢性疼痛是一种常见且使人衰弱的疾病，每年可显著降低医疗保健行业数百亿美元的成本。有证据表明，生酮（非常低的碳水化合物/高脂肪）饮食应该缓解两种类型的慢性疼痛，炎症性和神经性疼痛，最常见的是类风湿性关节炎和糖尿病，分别。该提案将量化两种生酮饮食在炎症和神经性疼痛的良好表征动物模型中的预防和缓解作用。